Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
16 April 2020 | Story Department of Communication and Marketing | Photo Charl Devenish
Farmovs
In 2019, FARMOVS was pre-qualified by the WHO to support clinical studies aimed at improving access to quality generic medicines across the globe.

The University of the Free State (UFS) is committed to supporting government’s efforts to overcome the COVID-19 pandemic. During this challenging time, dedicated staff members at the UFS continue to provide services as a testimony to their commitment to advance public knowledge of COVID-19 for the greater good of South Africa.

The following is a synopsis of the areas in which the UFS is actively assisting.

Public Health Emergency Solidarity Trial
Clinicians from the Department of Internal Medicine, the Department of Critical Care, and the Division of Virology will be working with FARMOVS to participate in the Public Health Emergency Solidarity Trial initiated by the World Health Organization (WHO). This international randomised trial will evaluate four treatment options (remdesivir, lopinavir/ritonavir, lopinavir/ritonavir plus interferon, chloroquine or hydroxychloroquine) for the treatment of COVID-19. 

The trial is expected to include more than 45 countries worldwide, including a number of South African sites. 

Farmovs

FARMOVS is in a planning process to support all the Bloemfontein hospitals, including Pelonomi, Universitas, 3 Military Hospital, Mediclinic, and Rosepark, in conducting the largest global trial on COVID-19 – the Public Health Emergency Solidarity Trial, under leadership of the WHO.   

Negotiations are ongoing between the UFS and the Department of Health in the Free State for FARMOVS to offer support with the continuation of healthcare to non-COVID-19 patients in an attempt to free up space at Universitas Hospital for isolation of COVID-19 patients. 

In 2019, FARMOVS was pre-qualified by the WHO to support clinical studies aimed at improving access to quality generic medicines across the globe.  FARMOVS also receives feasibility requests for support with the evaluation of existing drugs (repurposing) as well as the development of novel drugs for the treatment of COVID-19 – this is an ongoing process.

Disaster Management Training and Education Centre (DiMTEC)
DiMTEC represents the UFS on the Provincial Joint Operation Centre (PROVJOC). The PROVJOC is a fully equipped, dedicated facility that is proactively established to enable all relevant role players /disciplines to jointly manage all safety and security-related aspects of any planned event or any major incident which has occurred or is imminent – especially in the response and recovery operations phase – at the strategic and/or tactical level, using the Unified Command System. This facility is also linked to all other established safety and security centres.

Research and Innovation
The UFS hosts a SARChI Research Chair in vector-borne and zoonotic diseases, and recently invested in the establishment of a biosafety level-3 facility. Hence, there is expertise on the campus to plan and conduct research on zoonotic and medically significant viruses. In addition, there are research groups focusing on protein expression systems with potential for utilisation in the development of diagnostic assays with application in either diagnosis or surveillance.

Currently, researchers at the UFS have established several projects that will contribute directly towards the COVID-19 outbreak.


News Archive

Gastroenterology Unit works to bring a transformative impact to healthcare
2016-11-21

Description: Gastroenterology Unit  Tags: Gastroenterology Unit

Dr Rita Nathan, Acting CEO of Universitas Hospital,
Prof Willem Kruger, Acting Head of the
School of Medicine, and Prof Jan van Zyl,
Head of Department of Internal Medicine.
Photo: Nonsindiso Qwabe

The departments of Surgery and Internal Medicine at the University of Free State launched the newly upgraded Gastroenterology Unit of the Universitas Academic Hospital on 8 November 2016. Realising the need to provide state-of-the-art equipment that caters for various health needs, the unit has acquired new pieces of equipment worth R7 million. Through the equipment, a move towards the digital revolution, the unit hopes to bring about a transformative impact on healthcare service delivery in central South Africa and its surrounds.

Upgraded unit will make a difference on burden of diseases
Dr Rita Nathan, Acting CEO of the Universitas Hospital, said the increase in the number of scopes, and the improvement in technology, will facilitate improved service delivery to the community of the Free State and beyond. “This upgrade will enable the unit to make a tremendous dent in the burden of diseases in the communities we serve.”

Unit a unique feature in central South Africa

Serving a population from the Free State, Northern Cape, Eastern Cape and Lesotho; the growing demand of health services has led to an increase in the number of patients treated by the unit. This unit is unique in central South Africa as the only one providing endoscopic intervention for cases like gastrointestinal bleeding. It is also the only 24-hour gastroscopic service available in the state sector.

Improved service delivery linked to enhanced training platforms

Prof Willem Kruger, acting head of the School of Medicine, said that the upgrading of equipment will have an immense impact on not only service delivery, but also on training platforms in the latest technologies. “It important, as a university, that our doctors have the latest technology at their disposal to facilitate training. If training improves, service delivery improves. The two on inextricably linked.” he said.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept